Prognostic significance of E-Cadherin and B-Catenin in non-muscle invasive bladder cancer

References

• Ferlay, J.; Ervik, M.; Lam, F.; Colombet, M.; Mery, L.; Piñeros, M. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; https://gco.iarc.fr/today 2020 (accessed Mar 9, 2024).
   Google Scholar
• Sung, H.; Ferlay, J.; Siegel, R. L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71(3), 209–249. DOI: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Van Rhijn, B. W.; Burger, M.; Lotan, Y.; Solsona, E.; Stief, C. G.; Sylvester, R. J.; Witjes, J. A.; Zlotta, A. R. Recurrence and Progression of Disease in Non–Muscle-invasive Bladder Cancer: From Epidemiology to Treatment Strategy. Europ. Urol. 2009, 56(3), 430–442. DOI: 10.1016/j.eururo.2009.06.028.
   PubMed Web of Science ®Google Scholar
• Xylinas, E.; Kent, M.; Kluth, L.; Pycha, A.; Comploj, E.; Svatek, R. S.; Lotan, Y.; Trinh, Q.-D.; Karakiewicz, P. I.; Holmang, S., et al. Accuracy of the EORTC Risk Tables and of the CUETO Scoring Model to Predict Outcomes in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. Br. J. Cancer. 2013, 109(6), 1460–1466.
   PubMed Web of Science ®Google Scholar
• Liu, B.; Miyake, H.; Nishikawa, M.; Fujisawa, M. Expression Profile of Epithelial-Mesenchymal Transition Markers in Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Correlation with Intravesical Recurrence Following Transurethral Resection. Urol. Oncol. Mar 2015, 33(3), e110.11–e110.18. DOI: 10.1016/j.urolonc.2014.08.012.
   Web of Science ®Google Scholar
• Yazdi, S. A. M.; Sarab, B.; Tabriz, H. M.; Nazar, E.; Pourebrahimi, E. The Incidence and Prognostic Role of β-Catenin and E-Cadherin Biomarkers in Bladder Neoplasms, a Cross-Sectional Study. IJS. Open. May 2023, 54, 100609. DOI: 10.1016/j.ijso.2023.100609.
   Google Scholar
• Poletajew, S.; Fus, Ł.; Ilczuk, T.; Wojcieszak, P.; Sękowska, M.; Krajewski, W.; Wasiutyński, A.; Górnicka, B.; Radziszewski, P. Expression of E-Cadherin, β-Catenin, and Epithelial Membrane Antigen Does Not Predict Survival in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer. Cent. Eur. J. Immunol. 2018, 43(4), 421–427. DOI: 10.5114/ceji.2018.79509.
   PubMed Web of Science ®Google Scholar
• Breyer, J.; Gierth, M.; Shalekenov, S.; Aziz, A.; Schäfer, J.; Burger, M.; Denzinger, S.; Hofstädter, F.; Giedl, C.; Otto, W., et al. Epithelial–Mesenchymal Transformation Markers E-Cadherin and Survivin Predict Progression of Stage pTa Urothelial Bladder Carcinoma. World J. Urol. 2016, 34(5), 709–716.
   PubMed Web of Science ®Google Scholar
• Jang, T. J.; Cha, W. H.; Lee, K. S. Reciprocal Correlation Between the Expression of Cyclooxygenase-2 and E-Cadherin in Human Bladder Transitional Cell Carcinomas. Virchows. Arch. 2010, 457(3), 319–328. DOI: 10.1007/s00428-010-0943-3.
   PubMed Web of Science ®Google Scholar
• Ben Abdelkrim, S.; Rammeh, S.; Trabelsi, A.; Ben Yacoub Abid, L.; Anjorin, A.; Bdioui, A.; Jaïdane, L.; Mokni, M. Expression of E-Cadherin and β-Catenin in pTa/pT1 Transitional Cell Carcinoma of the Bladder. J. Afr. Cancer. 2011, 3(4), 217–221. DOI: 10.1007/s12558-011-0181-x.
   Google Scholar
• Guarino, M.; Rubino, B.; Ballabio, G. The Role of Epithelial–Mesenchymal Transition in Cancer Pathology. Pathology. 2007, 39(3), 305–318. DOI: 10.1080/00313020701329914.
   PubMed Web of Science ®Google Scholar
• Sato, M.; Shames, D. S.; Hasegawa, Y. Emerging Evidence of Epithelial-To-Mesenchymal Transition in Lung Carcinogenesis. Respirology. 2012, 17(7), 1048–1059. DOI: 10.1111/j.1440-1843.2012.02173.x.
   PubMed Web of Science ®Google Scholar
• Nakajima, S.; Doi, R.; Toyoda, E.; Tsuji, S.; Wada, M.; Koizumi, M.; Tulachan, S. S.; Ito, D.; Kami, K.; Mori, T., et al. N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma. Clin. Cancer Res. 2004, 10(12), 4125–4133.
   PubMed Web of Science ®Google Scholar
• Harten, S. K.; Shukla, D.; Barod, R.; Hergovich, A.; Balda, M. S.; Matter, K.; Esteban, M. A.; Maxwell, P. H. Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-Cadherin. MboC. 2009, 20(3), 1089–1101. DOI: 10.1091/mbc.e08-06-0566.
   Google Scholar
• Pyo, S. W.; Hashimoto, M.; Kim, Y. S.; Kim, C. H.; Lee, S. H.; Johnson, K. R.; Wheelock, M. J.; Park, J. U. Expression of E-Cadherin, P-Cadherin and N-Cadherin in Oral Squamous Cell Carcinoma: Correlation with Clinicopathologic Features and Patient Outcome. J. Maxillofac. Surg. 2007, 35(1), 1–9. DOI: 10.1016/j.jcms.2006.11.004.
   Web of Science ®Google Scholar
• Mhawech-Fauceglia, P.; Fischer, G.; Beck, A.; Cheney, R. T.; Herrmann, F. R. Raf1, Aurora-A/STK15 and E-Cadherin Biomarkers Expression in Patients with pTa/pT1 Urothelial Bladder Carcinoma; a Retrospective TMA Study of 246 Patients with Long-Term Follow-Up. Eur. J. Surg. Oncol. 2006, 32(4), 439–444. DOI: 10.1016/j.ejso.2006.01.018.
   PubMed Web of Science ®Google Scholar
• Hussein, S.; Mosaad, H.; Rashed, H. E.; Ahmed, S.; Ragab, A.; Ismail, E. I. Molecular Factors Regulating E-Cadherin Expression in Urothelial Bladder Cancer and Their Correlations with the Clinicopathological Features. Mol. Biol. Rep. 2017, 44(4), 365–377. DOI: 10.1007/s11033-017-4118-z.
   PubMed Web of Science ®Google Scholar
• Bryan, R. T., Atherfold, P. A., Yeo, Y., Jones, L. J., Harrison, R. F., Wallace, D., Jankowski, J. A. Cadherin Switching Dictates the Biology of Transitional Cell Carcinoma of the Bladder: Ex vivo and Ex vivo Studies. J. Pathol. 2008, 215(2), 184–194. DOI: 10.1002/path.2346.
   PubMed Web of Science ®Google Scholar
• Yang, T.; Fan, J.; Liang, H.; He, D.; Zeng, X.; Fan, J.; Wu, K. Reduced E-Cadherin Expression As a Prognostic Factor in Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Progrès en Urologie. 2020, 30(2), 66–74. DOI: 10.1016/j.purol.2019.12.004.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Liu, W.; Hayward, S. W.; Cunha, G. R.; Baskin, L. S. Plasticity of the Urothelial Phenotype: Effects of Gastro-Intestinal Mesenchyme/Stroma and Implications for Urinary Tract Reconstruction. Differentiation. 2000, 66(2–3), 126–135. DOI: 10.1046/j.1432-0436.2000.660207.x.
   PubMed Web of Science ®Google Scholar
• Muramaki, M.; Miyake, H.; Terakawa, T.; Kumano, M.; Sakai, I.; Fujisawa, M. Expression Profile of E-Cadherin and N-Cadherin in Non-Muscle-Invasive Bladder Cancer as a Novel Predictor of Intravesical Recurrence Following Transurethral Resection. Urol. Oncol. 2012, 30(2), 161–166. DOI: 10.1016/j.urolonc.2010.01.005.
   PubMed Web of Science ®Google Scholar
• Khorrami, M. H.; Hadi, M.; Gharaati, M. R.; Izadpanahi, M. H.; Javid, A.; Zargham, M. E-Cadherin Expression As a Prognostic Factor in Transitional Cell Carcinoma of the Bladder After Transurethral Resection. Urol. J. 2012, 9(3), 581–585.
   PubMed Web of Science ®Google Scholar
• Gudjónsson, S.; Bendahl, P. O.; Chebil, G.; Höglund, M.; Lindgren, D.; Lundberg, L. M.; Lövgren, K.; Fernö, M.; Månsson, W.; Liedberg, F., et al. Can Tissue Microarray-Based Analysis of Protein Expression Predict Recurrence of Stage Ta Bladder Cancer? Scand. J. Urol. 2011, 45(4), 270–277.
   Web of Science ®Google Scholar
• Xie, Y.; Li, P.; Gao, Y.; Gu, L.; Chen, L.; Fan, Y.; Zhang, F.; Zhang, X. Reduced E-Cadherin Expression Is Correlated with Poor Prognosis in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis. Oncotarget. 2017, 8(37), 62489–62499. DOI: 10.18632/oncotarget.19934.
   PubMedGoogle Scholar
• Moyano Calvo, J. L.; Blanco Palenciano, E.; Beato Moreno, A.; Beato Moreno, A.; Pérez-Lanzac Lorca, A.; Samaniego Torres, A.; Montaño, J. A.; Castiñeiras Fernández, J. Cadherina E, Catenina Beta, Antígeno Ki-67 y proteína p53 en el pronóstico de la recidiva tumoral en los tumores superficiales de vejiga T1. Actas. Urológicas. Españolas. 2006, 30(9), 871–878. DOI: 10.1016/S0210-4806(06)73553-7.
   PubMedGoogle Scholar
• Ren, J.; Yang, Y.; Peng, T.; Xu, D. Predictive Value of β-Catenin in Bladder Cancer: A Systematic Review and Meta-Analysis. Biosci. Rep. 2020, 40(9), BSR20202127. DOI: 10.1042/BSR20202127.
   Google Scholar